휴메딕스

200670KOSDAQView the 제약 sectorTheme Bio & healthcare

24,250KRWMarket close of 10/20 (Tue)

Down -3.00%-750KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)23,900KRWDown -1.44%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
24,700
High
25,350
Low
24,200
Day range
Day range low 24,200 high 25,350, open 24,700, close 24,250, previous close 25,000
Volume
1×10K shares
270.53 million KRW 0.40× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 22,600 to 52,300 won, 6% up from the low

6% of the way up from the lowest close in 1 year (252 sessions) · -53.6% from the high

Usual range

Nothing unusual in the 4 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
  • Daily moveusual range-3.00%-3.00%, 1.6× the usual (20-session average ±1.82%)
    That day -3.00% · usual ±1.82% · large-move threshold ±3.6%

The other 3 are within the usual range

  • Trading value0.4×usual range
  • EarningsOperating income, 4 quartersOperating income, 4 quarters
  • Data date10/20 (Tue)Market close
See the full check report

Quarterly results · Q4 2021

  • Revenue30.4B KRWRevenue bars for the last 4 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    +15.0%
  • Operating income4.7B KRWOperating income bars for the last 4 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    +48.5%
  • Operating margin15.4%Operating margin bars for the last 4 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    +3.5 pp

This quarter is derived: annual results minus Q1–Q3.

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2022-03-17
2021Q1 4.5B KRW2021Q4 4.7B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.